Characteristics of behavioural addiction in Parkinson’s disease patients with self-reported impulse control disorder and controls matched for levodopa equivalent dose: a matched case–control study

[1]  J. Kulisevsky,et al.  Predicting Impulse Control Disorders in Parkinson Disease through Incentive Biomarkers , 2022, Annals of neurology.

[2]  J. Trojanowski,et al.  Genetic prediction of impulse control disorders in Parkinson's disease , 2022, Annals of clinical and translational neurology.

[3]  I. Wilting,et al.  Impulse control disorders associated with dopaminergic drugs: A disproportionality analysis using vigibase , 2022, European Neuropsychopharmacology.

[4]  Jinyu Lu,et al.  Risk factors of impulsive-compulsive behaviors in PD patients: a meta-analysis , 2021, Journal of Neurology.

[5]  N. Dissanayaka,et al.  Unmasking neurobiological commonalities between addictive disorders and impulse control disorders in Parkinson’s disease , 2019, Brain Imaging and Behavior.

[6]  B. Mollenhauer,et al.  Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide , 2020, Movement disorders clinical practice.

[7]  Tai Chi,et al.  Movement Disorder , 2020, Definitions.

[8]  A. Strafella,et al.  Disrupted salience network dynamics in Parkinson's disease patients with impulse control disorders. , 2019, Parkinsonism & related disorders.

[9]  D. Berg,et al.  Assessment of cognitive-driven activity of daily living impairment in non-demented Parkinson's patients. , 2018, Journal of neuropsychology.

[10]  J. Kulisevsky,et al.  Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity , 2018, Front. Psychiatry.

[11]  M. Vidailhet,et al.  Longitudinal analysis of impulse control disorders in Parkinson disease , 2018, Neurology.

[12]  F. Durif,et al.  Impulse control disorders in Parkinson’s disease , 2018, Journal of Neural Transmission.

[13]  P. Derkinderen,et al.  Dopamine Agonists and Impulse Control Disorders: A Complex Association , 2017, Drug Safety.

[14]  G. Ebersbach,et al.  Impaired learning of punishments in Parkinson’s disease with and without impulse control disorder , 2017, Journal of Neural Transmission.

[15]  Mark Stacy,et al.  Clinical spectrum of impulse control disorders in Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[16]  V. Fung,et al.  Effect of impulse control disorders on disability and quality of life in Parkinson’s disease patients , 2014, Journal of Clinical Neuroscience.

[17]  T. van Eimeren,et al.  The Functional Anatomy of Impulse Control Disorders , 2013, Current Neurology and Neuroscience Reports.

[18]  M. Hornberger,et al.  Screening for impulse control symptoms in patients with de novo Parkinson disease: A case-control study , 2013, Neurology.

[19]  A. David,et al.  Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers , 2013, Neurology.

[20]  D. Weintraub,et al.  Impulse Control and Related Disorders in Parkinson’s Disease , 2012, Neurodegenerative Diseases.

[21]  H. Steiger,et al.  Cognitive-Behavioral Therapy for Pathological Gambling in Parkinson’s Disease: A Pilot Controlled Study , 2012, European Addiction Research.

[22]  P. Overton,et al.  Impulse Control Disorders in Parkinson’s Disease: A Psychosocial Perspective , 2012, Journal of Clinical Psychology in Medical Settings.

[23]  D. Bowers,et al.  Addiction-Like Manifestations and Parkinson's Disease: A Large Single Center 9-Year Experience , 2012, The International journal of neuroscience.

[24]  B. Averbeck,et al.  Novelty seeking behaviour in Parkinson's disease , 2011, Neuropsychologia.

[25]  Marios Politis,et al.  Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. , 2011, Brain : a journal of neurology.

[26]  W. Hall,et al.  Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field. , 2011, Addiction.

[27]  B. Averbeck,et al.  Altruistic punishment in patients with Parkinson's disease with and without impulsive behaviour , 2011, Neuropsychologia.

[28]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[29]  B. Averbeck,et al.  Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[30]  G. Ebersbach,et al.  [Non-motor Symptoms Questionnaire and Scale for Parkinson's disease. Cross-cultural adaptation into the German language]. , 2010, Der Nervenarzt.

[31]  A. Lang,et al.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. , 2010, Archives of neurology.

[32]  G. Ebersbach,et al.  Non-motor Symptoms Questionnaire und Scale für das idiopathische Parkinson-Syndrom , 2010, Der Nervenarzt.

[33]  M. Hallett,et al.  Mechanisms Underlying Dopamine-Mediated Reward Bias in Compulsive Behaviors , 2010, Neuron.

[34]  B. Jancin.  Tool Screens for Impulse-Control Disorders in Parkinson's , 2009 .

[35]  Daniel Weintraub,et al.  Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[36]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[37]  T. Robbins,et al.  Review Personality, Addiction, Dopamine: Insights from Parkinson's Disease Table 1. Possible Site of Striatal Dopamine Dysfunction Causing Different Motor and Cognitive Symptoms in Parkinson's Disease , 2022 .

[38]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[39]  E. Tolosa,et al.  Clinical diagnostic criteria for dementia associated with Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[40]  V. Voon,et al.  Medication-related impulse control and repetitive behaviors in Parkinson disease. , 2007, Archives of neurology.

[41]  A. Schapira.  Non-motor symptoms , 2006 .

[42]  P. Moberg,et al.  Association of dopamine agonist use with impulse control disorders in Parkinson disease. , 2006, Archives of neurology.

[43]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[44]  J. Aharon-Peretz,et al.  Novelty seeking and harm avoidance in Parkinson’s disease: effects of asymmetric dopamine deficiency , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[45]  R. Fitzpatrick,et al.  PDQ-39: a review of the development, validation and application of a Parkinson’s disease quality of life questionnaire and its associated measures , 1998, Journal of Neurology.

[46]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[47]  N. Nagelkerke,et al.  A note on a general definition of the coefficient of determination , 1991 .

[48]  H. Groenewegen,et al.  [Impulse control disorders in Parkinson's disease]. , 2011, Tijdschrift voor psychiatrie.

[49]  Mark Hallett,et al.  Impulsive choice and response in dopamine agonist-related impulse control behaviors , 2009, Psychopharmacology.

[50]  A. Mueller,et al.  [Impulse control disorders]. , 2009, Psychotherapie, Psychosomatik, medizinische Psychologie.

[51]  M. Bozkurt,et al.  Functional anatomy. , 1980, Equine veterinary journal.

[52]  J. Klein,et al.  Impulse control disorders in Parkinson disease and RBD A longitudinal study of severity , 2022 .